EditCo

EditCo operates as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), as well as an Oligonucleotide Supplier. The company has been recognised for its pivotal role in the gene editing landscape, contributing significantly to advancements in CRISPR technology. With a foundation built on years of expertise garnered within the innovative environment of Synthego, EditCo is dedicated to delivering high-quality reagents that are essential in driving scientific breakthroughs. Their advanced automated workflows reduce variability in cell functionality and performance, allowing researchers to make groundbreaking discoveries with confidence. This transformative approach is aimed at reimagining scientific research, empowering the community with tools that not only enhance the pace of innovation but also ensure the reliability of engineered cells as standard laboratory reagents.

Services include:
- Contract development and manufacturing of oligonucleotides
- Custom synthesis of high-quality reagents
- Automated workflows for enhanced reproducibility
- Support for CRISPR and gene editing applications
- Consultation and collaboration in research and development

EditCo is committed to advancing scientific inquiry and innovation through its comprehensive service offerings, ensuring that researchers have access to dependable resources. For more information, visit editco.bio.